SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-23-120998
Filing Date
2023-11-24
Accepted
2023-11-24 15:20:04
Documents
1
Group Members
ADAMS STREET 2016 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2017 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2018 DIRECT VENTURE/GROWTH FUND LPADAMS STREET 2019 DIRECT GROWTH EQUITY FUND LPADAMS STREET GROWTH EQUITY FUND VII LPADAMS STREET VENTURE/GROWTH FU

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2331516d1_sc13da.htm SC 13D/A 153759
  Complete submission text file 0001104659-23-120998.txt   155637
Mailing Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807
Business Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807 312-553-8486
ADAMS STREET PARTNERS LLC (Filed by) CIK: 0001193586 (see all company filings)

IRS No.: 364395178 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92771 | Film No.: 231436612
SIC: 2836 Biological Products, (No Diagnostic Substances)